Persistent chest pain and no obstructive coronary artery disease

JAMA

Volumn 301, Issue 14, 2009, Pages 1468-1474

  Phan, Anita ^a   Shufelt, Chrisandra ^a   Merz, C Noel Bairey ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; FENTANYL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; CARDIOVASCULAR AGENT; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ABNORMAL CARDIAC NOCICEPTION; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LOW DRUG DOSE; MICROVASCULAR CORONARY DYSFUNCTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX PAIN; BLOOD FLOW VELOCITY; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL OBSERVATION; CLINICAL STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; INTERVENTIONAL RADIOLOGY; MIDDLE AGED; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; SYNDROME X; TRANSCUTANEOUS NERVE STIMULATION;

ADULT; BLOOD FLOW VELOCITY; CARDIOVASCULAR AGENTS; CHEST PAIN; CORONARY CIRCULATION; CORONARY VASOSPASM; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; HUMANS; IMIPRAMINE; MICROVASCULAR ANGINA; MIDDLE AGED; NOCICEPTORS; PAIN MEASUREMENT; RADIOGRAPHY, INTERVENTIONAL; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; VASODILATOR AGENTS;

EID: 64249113535     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.425     Document Type: Article

References (51)

1. Diver DJ, Bier JD, Ferreira PE.et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 1994; 74(6):531-537.
2. Hochman JS, Tamis JE, Thompson TD, et al; Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes Mb Investigators. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999; 341(4):226-232.
3. Phibbs B, Fleming T, Ewy GA, et al. Frequency of normal coronary arteriograms in three academic medical centers and one community hospital. Am J Cardiol. 1988;62(7):472-474.
4. HalcoxJP,SchenkeWH,ZalosG,etal. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653-658.
5. SuwaidiJA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948-954.
6. von Mering GO, Arant CB, Wessel TR, et al; National Heart, Lung, and Blood Institute. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(6):722-725.
7. Lantinga LJ, Sprafkin RP, McCroskery JH, Baker MT, Warner RA, Hill NE. One-year psychosocial follow-up of patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 1988; 62(4):209-213.
8. Potts SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study. Psychol Med. 1995;25(2):339-347.
9. Isner JM, Salem DN, Banas JS Jr, Levine HJ. Longterm clinical course of patients with normal coronary arteriography: follow-up study of 121 patients with normal or nearly normal coronary arteriograms. Am Heart J. 1981;102(4):645-653.
10. Shaw LJ, Merz CN, Pepine CJ, et al; Women's Ischemia Syndrome Evaluation (WISE) Investigators. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation. 2006;114(9):894-904.
11. Reis SE, Holubkov R, Conrad Smith AJ, et al; WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141(5):735-741.
12. Cannon RO W,QuyyumiAA,MincemoyerR,etal. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994; 330(20):1411-1417.
13. Cooke RA, Anggiansah A, Smeeton NC, Owen WJ, Chambers JB. Gastroesophageal reflux in patients with angiographically normal coronary arteries: an uncommon cause of exertional chest pain. Br Heart J. 1994;72(3):231-236.
14. Wu EB, Cooke R, Anggiansah A, Owen W, Chambers JB. Are oesophageal disorders a common cause of chest pain despite normal coronary anatomy? QJM. 2000;93(8):543-550.
15. Katon W, Hall ML, Russo J, et al. Chest pain: relationship of psychiatric illness to coronary arteriographic results. Am J Med. 1988;84(1):1-9.
16. Zeiher AM, DrexlerH, WollschlagerH, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991;84(5):1984- 1992.
17. Bairey Merz CN, Pepine CJ, Johnson BD, Shaw LJ, Kelsey SF. Cardiac syndrome X: relation to microvascular angina and other conditions. Curr Cardiovasc Risk Rep. 2007;1:167-175.
18. Pepine CJ. Provoked coronary spasm and acute coronary syndromes. J Am Coll Cardiol. 2008; 52(7):528-530.
19. Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS. Myocardial bridging. Eur Heart J. 2005; 26(12):1159-1168.
20. Tsujita K, Maehara A, Mintz GS, et al. Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. Am J Cardiol. 2008; 102(12):1608-1613.
21. Quyyumi AA. Women and ischemic heart disease: pathophysiologic implications from the Wornen's Ischemia Syndrome Evaluation (WISE) study and future research steps. J Am Coll Cardiol. 2006; 47(3)(suppl):S66-S71.
22. Gulati MC-DR, McClure C, Johnson BD, et al. Adverse cardiovascular outcomes in women with no obstructive coronary artery disease: a report from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) project. Arch Intern Med. In press.
23. Qian J, Ge J, Baumgart D, et al. Safety of intracoronary Doppler flow measurement. Am Heart J. 2000;140(3):502-510.
24. Tio RA, Monnink SH, Amoroso G, et al. Safety evaluation of routine intracoronary acetylcholine infusion in patients undergoing a first diagnostic coronary angiogram. J Investig Med. 2002;50(2):133-139.
25. Hasdai D, Holmes DR Jr, Higano ST, Burnett JC Jr, Lerman A. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clln Proc. 1998;73(12):1133-1140.
26. Bairey Merz CN, Reis SE. Ischemic heart disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part II: gender-differences in presentation, diagnosis, and outcome with regard to sex-based pathophysiology of atherosclerosis, macro- and micro-vascular CAD. J Am Coll Cardiol. 2006;47(suppl):21S- 29S.
27. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40(3):505-510.
28. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA. 2005;293(4):477-484.
29. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association; Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-1374.
30. Simaitis A, Laucevicius A. [Effect of high doses of atorvastatin on the endothelial function of the coronary arteries]. Medicina (Kaunas). 2003;39(1): 21-29.
31. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J. 2003;24(22): 1999-2005.
32. Houghton JL, Pearson TA, Reed RG, et al. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms. Chest. 2000; 118(3):756-760.
33. Caliskan M, Erdogan D, Gullu H, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol. 2007;30(9):475-479.
34. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol. 2002;90(9):974-982.
35. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994;23(3):652-657.
36. Lanza GA, ColonnaG, Pasceri V.Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84(7):854-856.
37. Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol. 1989;63(5):286-290.
38. Cannon RO III, Watson RM, Rosing DR, Epstein SE. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol. 1985;56(4):242-246.
39. Cannon RO III, QuyyumiAA, SchenkeWH, etal. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol. 1990; 16(6):1359-1366.
40. Chauhan A, Mullins PA, Thuraisingham SI, Taylor G, Petch MC, Schofield PM. Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol. 1994; 24(2):329-335.
41. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ, Camici PG. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation. 1994;90(1):50-60.
42. Shapiro LM, Crake T, Poole-Wilson PA. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? clinical observation during cardiac catheterisation. Br Med J (Clin Res Ed). 1988;296(6616):170-171.
43. Lagerqvist B, Sylven C, Waldenstrom A. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms. Br Heart J. 1992;68(3):282-285.
44. Rosen SD, Paulesu E, Wise RJ, Camici PG. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002;87(6): 513-519.
45. Valeriani M, Sestito A, Le Pera D, et al. Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J. 2005;26(10):975-982.
46. Kelley BM, Porter JH. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of dozapine in rats. Pharmacol Biochem Behav. 1997;57(4):707-719.
47. Murray S, Collins PD, James MA. Neurostimulation treatment for angina pectoris. Heart. 2000; 83(2):217-220.
48. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A. Current and future treatment strategies for refractory angina. Mayo Clin Proc. 2004;79 (10):1284-1292.
49. Murray S, Carson KG, Ewings PD, Collins PD, James MA. Spinal cord stimulation significantly decreases the need for acute hospital admission for chest pain in patients with refractory angina pectoris. Heart. 1999; 82(1):89-92.
50. TenVaarwerk IA,Jessurun GA, DeJongste MJ, etal; Working Group on Neurocardiology. Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. Heart. 1999;82(1):82-88.
51. Chauhan A, Mullins PA, Thuraisingham SI, Taylor G, Petch MC, Schofield PM. Effect of transcutaneous electrical nerve stimulation on coronary blood flow. Circulation. 1994;89(2):694-702.